-
Study aim
-
Sleeve vs. Bypass in Weight Loss and Diabetes/Hypertension Control in Obese Patients 18–65
-
Design
-
Randomized, parallel, single blind trial with blinded outcome assessor; obese surgical candidates allocated to sleeve gastrectomy or gastric bypass. Block randomization with fixed block size four and one to one ratio; outcome assessor blinded. Follow up at one, three, six, and twelve months after surgery; comparing weight loss, diabetes and blood pressure control, complications, and quality of life.
-
Settings and conduct
-
Ali Ibn Abi Talib Hospital, Zahedan, Zahedan University of Medical Sciences. After approval and ethics code, eligible patients allocated to sleeve gastrectomy or gastric bypass. Surgery in operating room; follow-up in bariatric clinic of same hospital at months 1, 3, 6, 12.
-
Participants/Inclusion and exclusion criteria
-
Inclusion: Obese adults 18 to 65, bariatric candidates, BMI 40 or more, or BMI 35 or more with diabetes or hypertension, failed nonsurgical weight loss, psychological clearance, follow-up acceptance. Exclusion: Age outside 18 to 65, BMI below cutoff, pregnancy or lactation, type 1 or poorly controlled diabetes, severe cardiac, pulmonary, hepatic, or renal disease or malignant hypertension, psychiatric or substance abuse, eating disorder, IBD or malabsorption, prior bariatric or GI surgery, malignancy or active infection, coagulopathy or anesthesia contraindication, inability to follow up or consent.
-
Intervention groups
-
Intervention: sleeve gastrectomy versus Roux en Y gastric bypass; the latter as active comparator; identical care, follow up, and outcome assessment.
-
Main outcome variables
-
Body mass index, percent change in excess weight, glycated hemoglobin, systolic blood pressure, diastolic blood pressure.